Literature DB >> 14671633

Impairment of heart rate variability control during arsenic trioxide treatment for acute promyelocytic leukemia.

A Takeshita, A Uehara, K Shinjo, K Naito, N Sahara, K Yamazaki, H Katoh, T Kamikawa, K Ohnishi, M Maekawa, H Hayashi, R Ohno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14671633     DOI： 10.1038/sj.leu.2403248

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Assessment of heart rate response to exercise and recovery during treadmill testing in arsenic-exposed workers.

Authors:  Ugur Nadir Karakulak; Meside Gunduzoz; Mehmet Ayturk; Mujgan Tek Ozturk; Engin Tutkun; Omer Hinc Yilmaz
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-03-01       Impact factor: 1.468

2.  Is heart rate variability a valuable method to investigate cardiac autonomic dysfunction in subjects with leukemia? A systematic review to evaluate its importance in clinical practice.

Authors:  Jociele M Kirizawa; David M Garner; Claudia Arab; Vitor E Valenti
Journal:  Support Care Cancer       Date:  2019-08-23       Impact factor: 3.603

3.  Long-term cardiac-specific mortality among 44,292 acute myeloid leukemia patients treated with chemotherapy: a population-based analysis.

Authors:  Guangli Li; Zhijuan Zhou; Wencong Yang; Hao Yang; Xiuwu Fan; Yuelan Yin; Liyun Luo; Jinyou Zhang; Niujian Wu; Zibin Liang; Jianting Ke; Jian Chen
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.